TotalMarketCap

Acrivon Therapeutics

ACRVNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$67.280 M

$1.57 -9.77%

Close of 6 Nov 2026

As of 6 Nov 2026, Acrivon Therapeutics (ACRV) has a market capitalization of $67.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$77.9M

Loss-making

Shares outstanding

42,853,362

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #307MedicinovaMNOV$71.9M
  2. #308Rani TherapeuticsRANI$71.7M
  3. #309Acrivon TherapeuticsACRV$67.3M
  4. #310Zhengye BiotechnologyZYBT$66.8M
  5. #311Coya TherapeuticsCOYA$66.4M

What if Acrivon Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$658,918.52

Per share 419,693× higher

Bitcoin $1.53T

$35,652.93

Per share 22,709× higher

Apple $5.02T

$117,045.25

Per share 74,551× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Acrivon Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.